LHA ID: 879EUXH85J-6
Projects: GLA - German Lymphoma Alliance
Resource type: Experimental Assay Type
Technology type: Technology Type
Human Diseases: No human diseases
B-cell lymphoma is the most frequent lymphoid neoplasia accounting for one third of all lymphomas. R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone) is the current treatment standard, leading to high cure rates especially in younger patients. Although the 3-year event-free survival is about 60% even for elderly patients between 60-80 years old, the remainder of patients eventually relapse and the majority die of their disease. The German Non-Hodgkin's Lymphoma Study ...
Projects: HaematoSys - Systems biology of haematopoiesis and haematopoietic neoplasia, e:Med, CapSys - Systems Medicine of Community Acquired Pneumonia, LHA - Leipzig Health Atlas, LIFE Adult, LIFE - Leipzig Research Center for Civilization Diseases, LIFE HNC - Head and Neck Cancer Group, LIFE Child, GLA - German Lymphoma Alliance, MMML-MYC-SYS, HNPCC-Sys - Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome, MMML Demonstrators - Molecular Mechanisms in Malignant Lymphomas - Demonstrators of Personalized Medicine, CAPSys - Footprints of Sepsis Framed Within Community Acquired Pneumonia in the Blood Transcriptome, HaematoOpt - Individualized model-based managing of the next-cycle thrombopenia of CHOEP/CHOP treated patients based on platelets dynamics during the previous cycles, MMML - Molecular mechanisms in malignant lymphoma, GC-HNPCC - German Consortium for Hereditary Non-Polyposis Colorectal Cancer, GC-HBOC - German Consortium for Hereditary Breast and Ovarian Cancer, NLP4CR - Natural Language Processing for Clinical Research, LIFE Heart, ProstataCA, SepNet - German Competence Network Sepsis, Genetical Statistics and Systems Biology, GGN - German Glioma Network, COVID-19 Leipzig, SMITH - Smart Medical Information Technology for Healthcare, Management of health information systems, LivSys Transfer - Transfer of the LivSys in vitro system for hepatotoxicity into application, Project Test Demonstratorhttps://orcid.org/0000-0001-8344-0658